3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
43
Breast Neoplasms
31
Prostatic Neoplasms
27
Colorectal Neoplasms
26
Lung Neoplasms
17
Hematopoietic and Lymphatic System Neoplasm
12
Ovarian Neoplasms
11
Hematologic Neoplasms
11
Uterine Cervical Neoplasms
7
Multiple Myeloma
7
Lymphoma
7
Leukemia
7
Head and Neck Neoplasms
6
Endometrial Neoplasms
6
Depression
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Pancreatic Neoplasms
5
Leukemia, Myeloid, Acute
5
Urinary Bladder Neoplasms
4
Rectal Neoplasms
4
Mouth Neoplasms
4
Motor Activity
4
Melanoma
4
Hematopoietic and Lymphoid System Neoplasm
4
Gastrointestinal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Anxiety Disorders
4
Advanced Cancer
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Interventions
fludarabine
9
Cytarabine
9
venetoclax
5
fludarabine phosphate
5
Cyclophosphamide
5
Busulfan
5
thymoglobulin
4
Tacrolimus
4
Sirolimus
4
Mycophenolic Acid
4
Methotrexate
4
Azacitidine
4
aldesleukin
3
Whole-Body Irradiation
3
Interleukin-2
3
Antilymphocyte Serum
3
asciminib
2
Thiotepa
2
Peripheral Blood Stem Cell Transplantation
2
Mitoxantrone
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Etoposide
2
Dasatinib
2
Cyclosporine
2
Bone Marrow Transplantation
2
Blood Specimen Collection
2
Behavior Therapy
2
zileuton
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Leukemia, Myeloid
×
Interviews as Topic
×
Clear all
NCT05309018
2024-05-23
LAMIPA
Centre Hospitalier Régional Metz-Thionville
Withdrawn